- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on CAR T-Cell Therapy in United Kingdom
Total 1187 results
-
TetraLogic PharmaceuticalsUnknownCutaneous T-Cell Lymphoma (CTCL)United States
-
Yale UniversityEisai Inc.CompletedPeripheral T-Cell LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingAnaplastic Large Cell Lymphoma | Recurrent Angioimmunoblastic T-Cell Lymphoma | Recurrent Mycosis Fungoides | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Refractory Mycosis Fungoides | Refractory Anaplastic Large Cell Lymphoma | Subcutaneous... and other conditionsUnited States
-
University of NebraskaNational Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma, ALK-Positive | Hepatosplenic T-Cell Lymphoma | Peripheral T-Cell Lymphoma, Not Otherwise Specified | Anaplastic Large Cell Lymphoma, ALK-Negative | Stage II Angioimmunoblastic T-cell Lymphoma | Stage II Enteropathy-Associated T-Cell Lymphoma | Stage III Angioimmunoblastic... and other conditionsUnited States
-
Ohio State University Comprehensive Cancer CenterMerck Sharp & Dohme LLCActive, not recruitingSezary Syndrome | Chronic Lymphocytic Leukemia | Peripheral T-Cell Lymphoma | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | T-Cell Prolymphocytic Leukemia | B-Cell Prolymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma | Recurrent Adult Non-Hodgkin Lymphoma | Angioimmunoblastic T-Cell Lymphoma | Hepatosplenic T-Cell Lymphoma | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Adult T-Cell Leukemia/Lymphoma | Adult Nasal Type Extranodal NK/T-Cell LymphomaUnited States, Canada
-
Dartmouth-Hitchcock Medical CenterActive, not recruitingCutaneous T Cell Lymphoma | Graft Versus Host DiseaseUnited States
-
National Cancer Institute (NCI)CompletedSubcutaneous Panniculitis-Like T-Cell Lymphoma | T-Cell Peripheral Lymphoma | Gamma Delta Hepatosplenic T-Cell Lymphoma | NK T-Cell LymphomaUnited States
-
Eisai Inc.WithdrawnPeripheral T-Cell LymphomaUnited States
-
Jiangsu Simcere Pharmaceutical Co., Ltd.RecruitingAdvanced Solid Tumor | Cutaneous T-cell Lymphoma (CTCL)United States
-
OnxeoTerminatedNon-Hodgkin's Lymphoma | Cutaneous T-Cell Lymphoma | Peripheral T-Cell LymphomaUnited States, Germany, Israel, France, Thailand
-
UNC Lineberger Comprehensive Cancer CenterRecruiting
-
National Cancer Institute (NCI)CompletedMycosis Fungoides | Sezary Syndrome | Adult T-Cell Lymphoma/LeukemiaUnited States
-
University of Colorado, DenverBristol-Myers SquibbActive, not recruitingPeripheral T Cell LymphomaUnited States
-
University of Michigan Rogel Cancer CenterBristol-Myers SquibbCompletedPeripheral T Cell LymphomaUnited States
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedPeripheral T-Cell Lymphoma (PTCL)United States
-
John ReneauActive, not recruitingRecurrent T-Cell Non-Hodgkin Lymphoma | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma | Primary Cutaneous Anaplastic Large Cell Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma | Recurrent Nasopharyngeal Undifferentiated Carcinoma | Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 | Adult Nasal Type Extranodal NK/T-Cell Lymphoma | Stage IV Nasopharyngeal Undifferentiated Carcinoma...United States, Singapore, Japan, Hong Kong
-
Acrotech Biopharma Inc.RecruitingPeripheral T Cell LymphomaUnited States
-
Kymera Therapeutics, Inc.RecruitingSolid Tumors | T-cell Prolymphocytic Leukemia (T-PLL) | Non Hodgkin Lymphoma (NHL) | Peripheral T-cell Lymphoma (PTCL) | Cutaneous T-Cell Lymphoma (CTCL) | Large Granular Lymphocytic Leukemia (LGL-L)United States
-
University of MiamiRecruitingAdult T-cell Leukemia-Lymphoma | ATLLUnited States
-
Boston UniversityLigand PharmaceuticalsCompletedCutaneous T-Cell LymphomaUnited States
-
Seagen Inc.Active, not recruitingPeripheral T-cell LymphomaUnited States, Czechia, Italy, Spain, United Kingdom, France
-
TetraLogic PharmaceuticalsPPD; The Leukemia and Lymphoma Society; Veristat, Inc.; Therapeutics, Inc.CompletedLymphoma, T-Cell, CutaneousUnited States
-
Ellen Kim, MDSoligenixRecruitingMycosis Fungoides | Cutaneous T Cell LymphomaUnited States
-
University of PittsburghCompletedSezary Syndrome | Cutaneous T-cell LymphomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaUnited States, France, Italy, Poland, United Kingdom, Belgium, Germany, Spain, Belarus, Israel, Portugal, Bulgaria, Turkey, Canada, New Zealand, Peru, Brazil, Russian Federation, Chile, Puerto Rico, Australia, Austria, Hungary, Nether... and more
-
University of Alabama at BirminghamSeagen Inc.; Kyowa Kirin, Inc.RecruitingMycosis Fungoides | Cutaneous T Cell LymphomaUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Cutaneous T-cell Non-Hodgkin Lymphoma | Stage I Cutaneous T-cell Non-Hodgkin Lymphoma | Stage II Cutaneous T-cell Non-Hodgkin LymphomaUnited States
-
University of California, San FranciscoWashington University School of Medicine; Eisai Inc.TerminatedPeripheral T-Cell LymphomaUnited States
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedPeripheral T-Cell LymphomaUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationCompletedPreviously Untreated Peripheral T-cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedAcute Adult T-Cell Leukemia/Lymphoma | Adult T-Cell Leukemia/Lymphoma | Chronic Adult T-Cell Leukemia/Lymphoma | HTLV-1 Infection | Lymphomatous Adult T-Cell Leukemia/Lymphoma | Smoldering Adult T-Cell Leukemia/LymphomaUnited States
-
Tessa TherapeuticsActive, not recruitingAnaplastic Large Cell Lymphoma | Diffuse Large B Cell Lymphoma | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Primary Mediastinal Large B-Cell Lymphoma (PMBCL)United States
-
SoligenixCompletedCutaneous T-Cell Lymphoma/Mycosis FungoidesUnited States
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawn
-
Spectrum Pharmaceuticals, IncTerminatedPeripheral T-cell LymphomaBelgium, Spain, United States, Australia, France, Israel, Canada, United Kingdom, New Zealand, Italy, Ireland, Poland, Puerto Rico
-
Acrotech Biopharma Inc.CompletedCutaneous T-cell LymphomaUnited States
-
National Cancer Institute (NCI)RecruitingImmune System Diseases | Lymphoproliferative Disorders | Peripheral T-cell LymphomasUnited States
-
M.D. Anderson Cancer CenterCompletedLymphoma | Disorder Related to Bone Marrow TransplantationUnited States
-
Galderma R&DCompletedCutaneous T Cell LymphomaUnited States, France, Germany
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma | Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Refractory Mature T-Cell and NK-Cell Non-Hodgkin LymphomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); CelgeneActive, not recruitingPeripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Stage III Cutaneous T-cell Non-Hodgkin Lymphoma | Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma | Stage I Cutaneous... and other conditionsUnited States
-
Bausch Health Americas, Inc.CompletedRefractory Cutaneous T-cell LymphomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingNon Hodgkin Lymphoma | Relapsed T-Cell Lymphoma | Refractory T-Cell LymphomaUnited States
-
University of PittsburghCompletedMycosis Fungoides | Sezary Syndrome | Cutaneous T-cell LymphomaUnited States
-
University of PittsburghCompletedMycosis Fungoides | Sezary Syndrome | Cutaneous T-cell LymphomaUnited States
-
Eisai Inc.National Cancer Institute (NCI); Tufts Medical Center; Ligand PharmaceuticalsCompleted
-
Stanford UniversityTerminatedCutaneous T-cell Lymphoma | Cutaneous LymphomaUnited States